Elizabeth Plimack MD(@ERPlimackMD) 's Twitter Profileg
Elizabeth Plimack MD

@ERPlimackMD

Deputy Director @FoxChaseCancer. Professor GU Med Onc. @ASCO BOD 2020-24. Views mine. COI: https://t.co/fmmRpMCIWd

ID:2535434533

linkhttps://www.foxchase.org/elizabeth-plimack calendar_today30-05-2014 16:27:32

4,2K Tweets

7,2K Followers

1,1K Following

Follow People
Alexander Kutikov MD(@uretericbud) 's Twitter Profile Photo

@BCAN walk:
@BCAN is such an important resource that provides steadfast support for all bladder cancer patients. Thank you for all the incredible work that you do!

Thank you to Colleen Tetzlaff and Rosalia viterbo for organizing the great showing from…

#Philly @BCAN #BladderCancer walk: @BCAN is such an important resource that provides steadfast support for all bladder cancer patients. Thank you for all the incredible work that you do! Thank you to @Onc_PA_Mom and @RosaliaViterbo for organizing the great showing from…
account_circle
Fox Chase Cancer Center(@FoxChaseCancer) 's Twitter Profile Photo

In a study published in the journal Nature, researchers from Fox Chase have shown that a newly developed compound was able to block necroptosis, a type of cell death following infection with the influenza virus. Read more from Siddharth Balachandran, PhD: bit.ly/3VWiFjQ

In a study published in the journal Nature, researchers from Fox Chase have shown that a newly developed compound was able to block necroptosis, a type of cell death following infection with the influenza virus. Read more from Siddharth Balachandran, PhD: bit.ly/3VWiFjQ
account_circle
Enrique Grande(@drenriquegrande) 's Twitter Profile Photo

🙄 Dear members of the GU community. Let's see if someone can give me some advice how to explain to medical school students the data on PD1/L1 inhibitors in adjuvant RCC and UC.
It's for a friend 😳 OncoAlert GUARD Consortium
I leave them there together
👇👇👇👇👇👇👇👇👇👇

🙄 Dear members of the GU community. Let's see if someone can give me some advice how to explain to medical school students the data on PD1/L1 inhibitors in adjuvant RCC and UC. It's for a friend 😳 @OncoAlert @GuardConsortium I leave them there together 👇👇👇👇👇👇👇👇👇👇
account_circle
Dr. Kimryn Rathmell(@NCIDirector) 's Twitter Profile Photo

I’ll be speaking at several sessions at . Hope you’ll join! spr.ly/6012wEZya
👉 Sunday 4/7: Opening Ceremony
👉 Monday 4/8: NCI Director’s Address + Fireside Chat with AACR President Patricia M. LoRusso
👉 Tuesday 4/9: Panel on the and the

account_circle
Fox Chase Cancer Center(@FoxChaseCancer) 's Twitter Profile Photo

We're proud to share that camille ragin, PhD, will be awarded the 2024 AACR-Minorities in Cancer Research Jane Cooke Wright Award Lectureship during the American Association for Cancer Research Annual Meeting in San Diego. Read more on Healio: bit.ly/49p2lLJ

account_circle
Lucia Borriello(@luciaborriell) 's Twitter Profile Photo

Congratulations to Dr. Eti Cukierman Dr. Edna Cukierman, Ph.D. for receiving the Marvin and Concetta Greenberg Endowed Chair! You are a role model, a kind, unique and exemplary scientist, colleague, and friend! Fox Chase Cancer Center

Congratulations to Dr. Eti Cukierman @ednacukierman for receiving the Marvin and Concetta Greenberg Endowed Chair! You are a role model, a kind, unique and exemplary scientist, colleague, and friend! @FoxChaseCancer
account_circle
Matt Nielsen, MD(@m_e_nielsen) 's Twitter Profile Photo

Cheers to UNC School of Medicine Class of 2024 for picking Angie Smith to share
🎯🎯🎯 advice:

✅embrace the challenge / discomfort of adventure
✅the quality of your life determined by the focus of your attention
✅find your crew

👀➡️ youtube.com/live/_LLkTMUTI…

Cheers to @UNC_SOM Class of 2024 for picking @angiesmith_uro to share 🎯🎯🎯 #MatchDay advice: ✅embrace the challenge / discomfort of adventure ✅the quality of your life determined by the focus of your attention ✅find your crew 👀➡️ youtube.com/live/_LLkTMUTI…
account_circle
LKSOM Status of Women Faculty Committee(@OwlWomenFaculty) 's Twitter Profile Photo

Lewis Katz School of Medicine community: Nominate a colleague for Group on Women in Medicine and Science Leadership Award! Nomination of leaders and that have significant impact on advancing women leaders in academic medicine and science is encouraged. More info ⬇️. abstractscorecard.com/cfp/submit/log…

account_circle
Elizabeth Plimack MD(@ERPlimackMD) 's Twitter Profile Photo

We witness abuse every day in oncology - this short documentary sums it up. Independence Blue Cross UnitedHealthcare Cigna Healthcare Stop obstructing + delaying standard quality care in the name of profit. Thank you The New York Times Shikha Jain MD, FACP and ASCO for shining the light and advocating for change

account_circle
KidneyCAN(@kidneycan) 's Twitter Profile Photo

$50,000 could fuel your research project!

KidneyCAN + AACR present the Kidney Cancer Innovation and Discovery Grants. Submit your one-page proposal for the opportunity to propel your work and our mission forward!

bit.ly/AACR-KidneyCAN…

$50,000 could fuel your #kidneycancer research project! KidneyCAN + @AACR present the Kidney Cancer Innovation and Discovery Grants. Submit your one-page proposal for the opportunity to propel your work and our mission forward! bit.ly/AACR-KidneyCAN… #AcceleratingCures
account_circle
Brian Rini, MD(@brian_rini) 's Twitter Profile Photo

Updated table of IO combos (ITT population) in front line mRCC after . Has anything changed for you based on these data?

Updated table of IO combos (ITT population) in front line mRCC after #ASCOGU24. Has anything changed for you based on these data?
account_circle
Journal of Clinical Oncology(@JCO_ASCO) 's Twitter Profile Photo

We're excited to announce the launch of JCO Oncology Advances, a new journal making cancer research accessible! Thrilled to welcome Pamela Kunz, MD, FASCO as Editor-in-Chief, leading the charge in bridging science and care.

Learn more: brnw.ch/21wGw6h

We're excited to announce the launch of JCO Oncology Advances, a new journal making cancer research accessible! Thrilled to welcome @PamelaKunzMD as Editor-in-Chief, leading the charge in bridging science and care. Learn more: brnw.ch/21wGw6h #OncTwitter
account_circle
Bladder Cancer Advocacy Network(@BladderCancerUS) 's Twitter Profile Photo

PLEASE SHARE => BCAN's $75,000 Young Investigator and Patient-Centered Clinical Young Investigator Awards are accepting applications, but only until Feb 22nd. Advance your career and network with distinguished members of the community. Learn more and apply here:…

PLEASE SHARE => BCAN's $75,000 Young Investigator and Patient-Centered Clinical Young Investigator Awards are accepting applications, but only until Feb 22nd. Advance your career and network with distinguished members of the #bladdercancer community. Learn more and apply here:…
account_circle
Malorie Simons(@DrMalSimons) 's Twitter Profile Photo

📢‼️ Calling applying for Advanced Endo Fellowship ‼️

Fox Chase Cancer Center in Philadelphia now offers a 4th yr Interventional Endo Fellowship

Learn/train with THE 💪trifecta: David Loren, Joe Triggs and Me!

ASGE GI Endoscopy American Gastroenterological Association (AGA)

foxchase.org/research-train…

📢‼️ Calling #GITwitter applying for Advanced Endo Fellowship ‼️ @FoxChaseCancer in Philadelphia now offers a 4th yr Interventional Endo Fellowship Learn/train with THE 💪trifecta: David Loren, Joe Triggs and Me! @ASGEendoscopy @AmerGastroAssn foxchase.org/research-train…
account_circle
Hoosier Cancer(@hoosiercancer) 's Twitter Profile Photo

Nearly 30 members of our GU Working Group attended a session to review clinical trial concepts and brainstorm on new ideas this morning. Thanks to co-chairs Rana McKay and Shilpa Gupta for their leadership. ASCO

Nearly 30 members of our GU Working Group attended a session to review clinical trial concepts and brainstorm on new ideas this morning. Thanks to co-chairs @DrRanaMcKay and @shilpaonc for their leadership. @ASCO #asco24
account_circle
Elizabeth Plimack MD(@ERPlimackMD) 's Twitter Profile Photo

re FAV risk on IpiNivo: Pts have to get to CR/PR to earn a coveted spot on that DOR curve and sadly only 30% do (vs 68% with len pembro) From there only 17% (21 pts) made it to the 2 year inflection point when they saw benefit over sutent, and no OS plateau yet...

account_circle